GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM120750
Query DataSets for GSM120750
Status
Public on Jul 18, 2006
Title
END-ALS-3aUB-S2
Sample type
RNA
Source name
Human skeletal muscle
Organism
Homo sapiens
Characteristics
disease state:ALS;
Extracted molecule
total RNA
Label
biotin
Hybridization protocol
standard Affymetrix procedures
Scan protocol
standard Affymetrix procedures
Description
Idenitify pathophysiological pathway invloved in muscle atrophy due to denervation in ALS patients
Data processing
MAS5.0
Submission date
Jul 17, 2006
Last update date
Oct 01, 2019
Contact name
Eric P Hoffman
E-mail(s)
[email protected]
Organization name
Binghamton University - SUNY
Department
Pharmaceutical Sciences
Street address
PO Box 6000
City
Binghamton
State/province
NY
ZIP/Postal code
13902
Country
USA
Platform ID
GPL97
Series (1)
GSE3307
Comparative profiling in 13 muscle disease groups
Data table header descriptions
ID_REF
VALUE
SIGNAL (See Affymetrix Literature)
ABS_CALL
Data table
ID_REF
VALUE
ABS_CALL
200000_s_at
6183.568359375
P
200001_at
14358.353515625
P
200002_at
25350.697265625
P
200003_s_at
27309.150390625
P
200004_at
25422.404296875
P
200005_at
7621.92578125
P
200006_at
40587.5625
P
200007_at
20574.99609375
P
200008_s_at
5910.45556640625
P
200009_at
12431.0185546875
P
200010_at
28398.115234375
P
200011_s_at
2480.1943359375
P
200012_x_at
25802.048828125
P
200013_at
28543.615234375
P
200014_s_at
5104.96728515625
P
200015_s_at
7531.24462890625
P
200016_x_at
25697.7578125
P
200017_at
31633.453125
P
200018_at
37579.33203125
P
200019_s_at
33143.328125
P
Total number of rows:
22645
Table truncated, full table size
668 Kbytes
.
Supplementary file
Size
Download
File type/resource
GSM120750.CEL.gz
4.0 Mb
(ftp)
(http)
CEL
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|